Heparin Market

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.

Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

Heparin Market is revolving around Heparin Active Pharmaceutical Ingredients (API).

Heparin Market contains market size and forecasts of Heparin(Heparin Sodium and Heparin Calcium) in global, including the following market information:

Global Heparin(Heparin Sodium and Heparin Calcium) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Heparin(Heparin Sodium and Heparin Calcium) Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Heparin(Heparin Sodium and Heparin Calcium) companies in 2021 (%)

The global Heparin(Heparin Sodium and Heparin Calcium) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Heparin Sodium Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Heparin(Heparin Sodium and Heparin Calcium) include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen (N.V.Organon), King-friend Biochemical Pharmaceutical, Bioib?rica and Dongcheng Biochemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Heparin(Heparin Sodium and Heparin Calcium) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Heparin(Heparin Sodium and Heparin Calcium) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Heparin(Heparin Sodium and Heparin Calcium) Market Segment Percentages, by Type, 2021 (%)

Heparin Sodium

Heparin Calcium

Global Heparin(Heparin Sodium and Heparin Calcium) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Heparin(Heparin Sodium and Heparin Calcium) Market Segment Percentages, by Application, 2021 (%)

Unfractionated Heparin

Low Molecular Heparin API

Global Heparin(Heparin Sodium and Heparin Calcium) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Heparin(Heparin Sodium and Heparin Calcium) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Heparin(Heparin Sodium and Heparin Calcium) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Heparin(Heparin Sodium and Heparin Calcium) revenues share in global market, 2021 (%)

Key companies Heparin(Heparin Sodium and Heparin Calcium) sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Heparin(Heparin Sodium and Heparin Calcium) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Hepalink

Changshan Pharm

Qianhong Bio-pharma

Opocrin

Pfizer

Aspen (N.V.Organon)

King-friend Biochemical Pharmaceutical

Bioib?rica

Dongcheng Biochemicals

Jiulong Biochemicals

Tiandong

Xinbai

Yino Pharma Limited

Deebio